指南与共识神经介入DSA

破裂颅内动脉瘤支架辅助栓塞与血流导向术的抗血小板管理:DELPHI共识声明

Antiplatelet Management for Stent-Assisted Coiling and Flow Diversion of Ruptured Intracranial Aneurysms: A DELPHI Consensus Statement.
指南 / 共识 · AJNR Am J Neuroradiol · 2020-09-17

针对破裂颅内动脉瘤行支架辅助栓塞或血流导向术的抗血小板管理数据匮乏问题,采用改良DELPHI法向15名国际神经介入专家多轮发送在线问卷。专家共识认为血小板功能检测可能不必要,围术期首选阿司匹林联合糖蛋白IIb/IIIa抑制剂双联静脉抗血小板方案,术后24小时内可转换为口服阿司匹林和P2Y12抑制剂。

要点

  • 共识认为血小板功能检测可能不必要,破裂动脉瘤支架辅助栓塞与血流导向术的抗血小板管理可遵循相同原则。
  • 围术期标准方案首选阿司匹林联合糖蛋白IIb/IIIa抑制剂的静脉双联抗血小板治疗。
  • 术后24小时内可将静脉药物转换为口服阿司匹林和P2Y12抑制剂。

诊断标准与关键数值

  • 专家组达成共识:血小板功能检测可能不必要。
  • 专家组达成共识:破裂颅内动脉瘤支架辅助栓塞和血流导向术的抗血小板管理可遵循相同原则。
  • 对于脑积水高风险病例,术前放置脑室引流被认为有益。
  • 围术期双联静脉抗血小板方案(阿司匹林联合糖蛋白IIb/IIIa抑制剂)被首选为标准方案。
  • 专家组同意术后24小时内可将静脉药物转换为口服阿司匹林和口服P2Y12抑制剂。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文指出关于破裂颅内动脉瘤行支架辅助栓塞或血流导向术患者的抗血小板管理,亟需更多更好的数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: There is a paucity of data regarding antiplatelet management strategies in the setting of stent-assisted coiling/flow diversion for ruptured intracranial aneurysms. This study aimed to identify current challenges in antiplatelet management during stent-assisted coiling/flow diversion for ruptured intracranial aneurysms and to outline possible antiplatelet management strategies.

MATERIALS AND METHODS: The modified DELPHI approach with an on-line questionnaire was sent in several iterations to an international, multidisciplinary panel of 15 neurointerventionalists. The first round consisted of open-ended questions, followed by closed-ended questions in the subsequent rounds. Responses were analyzed in an anonymous fashion and summarized in the final manuscript draft. The statement received endorsement from the World Federation of Interventional and Therapeutic Neuroradiology, the Japanese Society for Neuroendovascular Therapy, and the Chinese Neurosurgical Society.

RESULTS: Data were collected from December 9, 2019, to March 13, 2020. Panel members achieved consensus that platelet function testing may not be necessary and that antiplatelet management for stent-assisted coiling and flow diversion of ruptured intracranial aneurysms can follow the same principles. Preprocedural placement of a ventricular drain was thought to be beneficial in cases with a high risk of hydrocephalus. A periprocedural dual, intravenous, antiplatelet regimen with aspirin and a glycoprotein IIb/IIIa inhibitor was preferred as a standard approach. The panel agreed that intravenous medication can be converted to oral aspirin and an oral P2Y12 inhibitor within 24 hours after the procedure.

CONCLUSIONS: More and better data on antiplatelet management of patients with ruptured intracranial aneurysms undergoing stent-assisted coiling or flow diversion are urgently needed. Panel members in this DELPHI consensus study preferred a periprocedural dual-antiplatelet regimen with aspirin and a glycoprotein IIb/IIIa inhibitor.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Ospel JM, Brouwer P, Dorn F, et al. Antiplatelet Management for Stent-Assisted Coiling and Flow Diversion of Ruptured Intracranial Aneurysms: A DELPHI Consensus Statement. AJNR Am J Neuroradiol. 2020. PMID: 32943417. doi:10.3174/ajnr.A6814

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。